Price Increases Help Biogen Lift Revenue - WSJ.com
Links shared publicly online about this topic.
- 1,893total visits
Price Increases Help Biogen Lift Revenue - WSJ.com
Biogen boosted revenue 10%, aided greatly by a 22% price increase for multiple sclerosis drug Avonex, its top-selling product.
View full resource at online.wsj.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Avonex
Most Recently Shared on July 16, 2009 at 1:17 pm By:
Biogen Posts 31% Drop in Profit http://bit.ly/CTr4z
Advertisement
